NEUROCRINE BIOSCIENCES INC Comprehensive Income
NEUROCRINE BIOSCIENCES INC (NBIX) reported Comprehensive Income of $149.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $149.10M, a 34.32% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $185.20M, a 1568.47% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $153.60M, a 62.71% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $210.20M, a 48.24% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $485.90M, a 42.87% increase from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $340.10M, a 28.53% increase from fiscal 2023.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $264.60M, a 78.42% increase from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $148.30M, a 72.24% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $149.10M 10-Q · filed 2026-07-31 | $334.30M 10-Q · filed 2026-07-31 | $487.90M derived: sum of 3 quarters · filed 2026-07-31 | $698.10M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | $185.20M 10-Q · filed 2026-05-05 | $338.80M derived: sum of 2 quarters · filed 2026-05-05 | $549.00M derived: sum of 3 quarters · filed 2026-05-05 | $660.00M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | $153.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $363.80M derived: sum of 2 quarters · filed 2026-02-11 | $474.80M derived: sum of 3 quarters · filed 2026-07-31 | $485.90M 10-K · filed 2026-02-11 | |||
| 2025-09-30 | $210.20M 10-Q · filed 2025-10-28 | $321.20M derived: sum of 2 quarters · filed 2026-07-31 | $332.30M 10-Q · filed 2025-10-28 | $426.70M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | $111.00M 10-Q · filed 2026-07-31 | $122.10M 10-Q · filed 2026-07-31 | $216.50M derived: sum of 3 quarters · filed 2026-07-31 | $358.30M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-03-31 | $11.10M 10-Q · filed 2026-05-05 | $105.50M derived: sum of 2 quarters · filed 2026-05-05 | $247.30M derived: sum of 3 quarters · filed 2026-05-05 | $311.50M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $94.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $236.20M derived: sum of 2 quarters · filed 2026-02-11 | $300.40M derived: sum of 3 quarters · filed 2026-02-11 | $340.10M 10-K · filed 2026-02-11 | |||
| 2024-09-30 | $141.80M 10-Q · filed 2025-10-28 | $206.00M derived: sum of 2 quarters · filed 2025-10-28 | $245.70M 10-Q · filed 2025-10-28 | $402.10M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | $64.20M 10-Q · filed 2025-07-30 | $103.90M 10-Q · filed 2025-07-30 | $260.30M derived: sum of 3 quarters · filed 2026-02-11 | $342.80M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-03-31 | $39.70M 10-Q · filed 2025-05-05 | $196.10M derived: sum of 2 quarters · filed 2026-02-11 | $278.60M derived: sum of 3 quarters · filed 2026-02-11 | $375.70M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | $156.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $238.90M derived: sum of 2 quarters · filed 2026-02-11 | $336.00M derived: sum of 3 quarters · filed 2026-02-11 | $264.60M 10-K · filed 2026-02-11 | |||
| 2023-09-30 | $82.50M 10-Q · filed 2024-10-30 | $179.60M derived: sum of 2 quarters · filed 2024-10-30 | $108.20M 10-Q · filed 2024-10-30 | $203.30M derived: sum of 4 quarters · filed 2025-02-10 | |||
| 2023-06-30 | $97.10M 10-Q · filed 2024-08-01 | $25.70M 10-Q · filed 2024-08-01 | $120.80M derived: sum of 3 quarters · filed 2025-02-10 | $187.50M derived: sum of 4 quarters · filed 2025-02-10 | |||
| 2023-03-31 | -$71.40M 10-Q · filed 2024-05-01 | $23.70M derived: sum of 2 quarters · filed 2025-02-10 | $90.40M derived: sum of 3 quarters · filed 2025-02-10 | $70.60M derived: sum of 4 quarters · filed 2025-02-10 | |||
| 2022-12-31 | $95.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $161.80M derived: sum of 2 quarters · filed 2025-02-10 | $142.00M derived: sum of 3 quarters · filed 2025-02-10 | $148.30M 10-K · filed 2025-02-10 | |||
| 2022-09-30 | $66.70M 10-Q · filed 2023-10-31 | $46.90M derived: sum of 2 quarters · filed 2023-10-31 | $53.20M 10-Q · filed 2023-10-31 | $43.80M derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-06-30 | -$19.80M 10-Q · filed 2023-08-01 | -$13.50M 10-Q · filed 2023-08-01 | -$22.90M derived: sum of 3 quarters · filed 2024-02-09 | -$700.00K derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-03-31 | $6.30M 10-Q · filed 2023-05-03 | -$3.10M derived: sum of 2 quarters · filed 2024-02-09 | $19.10M derived: sum of 3 quarters · filed 2024-02-09 | $61.10M derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2021-12-31 | -$9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $12.80M derived: sum of 2 quarters · filed 2024-02-09 | $54.80M derived: sum of 3 quarters · filed 2024-02-09 | $86.10M 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $22.20M 10-Q · filed 2022-11-01 | $64.20M derived: sum of 2 quarters · filed 2022-11-01 | $95.50M 10-Q · filed 2022-11-01 | $442.00M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-06-30 | $42.00M 10-Q · filed 2022-08-04 | $73.30M 10-Q · filed 2022-08-04 | $419.80M derived: sum of 3 quarters · filed 2023-02-09 | $360.80M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-03-31 | $31.30M 10-Q · filed 2022-05-04 | $377.80M derived: sum of 2 quarters · filed 2023-02-09 | $318.80M derived: sum of 3 quarters · filed 2023-02-09 | $404.40M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | $346.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $287.50M derived: sum of 2 quarters · filed 2023-02-09 | $373.10M derived: sum of 3 quarters · filed 2023-02-09 | $407.70M 10-K · filed 2023-02-09 | |||
| 2020-09-30 | -$59.00M 10-Q · filed 2021-11-01 | $26.60M derived: sum of 2 quarters · filed 2021-11-01 | $61.20M 10-Q · filed 2021-11-01 | $95.00M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-06-30 | $85.60M 10-Q · filed 2021-08-03 | $120.20M 10-Q · filed 2021-08-03 | $154.00M derived: sum of 3 quarters · filed 2022-02-11 | $208.80M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-03-31 | $34.60M 10-Q · filed 2021-05-05 | $68.40M derived: sum of 2 quarters · filed 2022-02-11 | $123.20M derived: sum of 3 quarters · filed 2022-02-11 | $175.40M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2019-12-31 | $33.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $88.60M derived: sum of 2 quarters · filed 2022-02-11 | $140.80M derived: sum of 3 quarters · filed 2022-02-11 | $40.40M 10-K · filed 2022-02-11 | $40.36M 10-K · filed 2020-02-07 | ||
| 2019-09-30 | $54.80M 10-Q · filed 2020-11-09 | $54.75M 10-Q · filed 2019-11-04 | $107.00M derived: sum of 2 quarters · filed 2020-11-09 | $6.60M 10-Q · filed 2020-11-09 | $6.55M 10-Q · filed 2019-11-04 | $24.77M derived: sum of 4 quarters · filed 2021-02-05 | |
| 2019-06-30 | $52.20M 10-Q · filed 2020-08-03 | $52.22M 10-Q · filed 2019-07-29 | -$48.20M 10-Q · filed 2020-08-03 | -$30.03M derived: sum of 3 quarters · filed 2021-02-05 | $21.49M derived: sum of 4 quarters · filed 2021-02-05 | ||
| 2019-03-31 | -$100.40M 10-Q · filed 2020-05-06 | -$100.42M 10-Q · filed 2019-04-29 | -$82.23M derived: sum of 2 quarters · filed 2021-02-05 | -$30.71M derived: sum of 3 quarters · filed 2021-02-05 | -$35.73M derived: sum of 4 quarters · filed 2021-02-05 | ||
| 2018-12-31 | $18.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | $69.69M derived: sum of 2 quarters · filed 2021-02-05 | $64.67M derived: sum of 3 quarters · filed 2021-02-05 | $21.00M 10-K · filed 2021-02-05 | $21.03M 10-K · filed 2019-02-08 | ||
| 2018-09-30 | $51.52M 10-Q · filed 2019-11-04 | $46.49M derived: sum of 2 quarters · filed 2019-11-04 | $2.83M 10-Q · filed 2019-11-04 | $8.40M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | -$5.03M 10-Q · filed 2019-07-29 | -$48.69M 10-Q · filed 2019-07-29 | -$43.11M derived: sum of 3 quarters · filed 2020-02-07 | -$54.06M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-03-31 | -$43.66M 10-Q · filed 2019-04-29 | -$38.09M derived: sum of 2 quarters · filed 2020-02-07 | -$49.03M derived: sum of 3 quarters · filed 2020-02-07 | -$109.50M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | -$5.37M derived: sum of 2 quarters · filed 2020-02-07 | -$65.83M derived: sum of 3 quarters · filed 2020-02-07 | -$144.07M 10-K · filed 2020-02-07 | |||
| 2017-09-30 | -$10.95M 10-Q · filed 2018-11-05 | -$71.41M derived: sum of 2 quarters · filed 2018-11-05 | -$149.65M 10-Q · filed 2018-11-05 | -$194.44M derived: sum of 4 quarters · filed 2019-02-08 | |||
| 2017-06-30 | -$60.46M 10-Q · filed 2018-07-31 | -$138.71M 10-Q · filed 2018-07-31 | -$183.50M derived: sum of 3 quarters · filed 2019-02-08 | -$220.53M derived: sum of 4 quarters · filed 2019-02-08 | |||
| 2017-03-31 | -$78.24M 10-Q · filed 2018-04-30 | -$123.03M derived: sum of 2 quarters · filed 2019-02-08 | -$160.07M derived: sum of 3 quarters · filed 2019-02-08 | -$200.20M derived: sum of 4 quarters · filed 2019-02-08 | |||
| 2016-12-31 | -$44.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | -$81.83M derived: sum of 2 quarters · filed 2019-02-08 | -$121.96M derived: sum of 3 quarters · filed 2019-02-08 | -$140.43M 10-K · filed 2019-02-08 | |||
| 2016-09-30 | -$37.03M 10-Q · filed 2017-11-01 | -$77.17M derived: sum of 2 quarters · filed 2017-11-01 | -$95.64M 10-Q · filed 2017-11-01 | -$125.32M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | -$40.13M 10-Q · filed 2017-08-03 | -$58.61M 10-Q · filed 2017-08-03 | -$88.29M derived: sum of 3 quarters · filed 2018-02-13 | -$122.93M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | -$18.48M 10-Q · filed 2017-05-09 | -$48.16M derived: sum of 2 quarters · filed 2018-02-13 | -$82.80M derived: sum of 3 quarters · filed 2018-02-13 | -$107.01M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | -$29.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$64.32M derived: sum of 2 quarters · filed 2018-02-13 | -$88.53M derived: sum of 3 quarters · filed 2018-02-13 | -$89.63M 10-K · filed 2018-02-13 | |||
| 2015-09-30 | -$34.64M 10-Q · filed 2016-11-02 | -$58.85M derived: sum of 2 quarters · filed 2016-11-02 | -$59.95M 10-Q · filed 2016-11-02 | -$79.46M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-30 | -$24.21M 10-Q · filed 2016-08-03 | -$25.31M 10-Q · filed 2016-08-03 | -$44.82M derived: sum of 3 quarters · filed 2017-02-14 | -$60.78M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-31 | -$1.09M 10-Q · filed 2016-05-05 | -$20.61M derived: sum of 2 quarters · filed 2017-02-14 | -$36.56M derived: sum of 3 quarters · filed 2017-02-14 | -$49.88M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-31 | -$19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$35.47M derived: sum of 2 quarters · filed 2017-02-14 | -$48.78M derived: sum of 3 quarters · filed 2017-02-14 | -$60.82M 10-K · filed 2017-02-14 | |||
| 2014-09-30 | -$15.96M 10-Q · filed 2015-10-29 | -$29.27M derived: sum of 2 quarters · filed 2015-10-29 | -$41.31M 10-Q · filed 2015-10-29 | -$51.94M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | -$13.31M 10-Q · filed 2015-07-29 | -$25.35M 10-Q · filed 2015-07-29 | -$35.98M derived: sum of 3 quarters · filed 2016-02-11 | -$47.08M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | -$12.04M 10-Q · filed 2015-04-30 | -$22.67M derived: sum of 2 quarters · filed 2016-02-11 | -$33.77M derived: sum of 3 quarters · filed 2016-02-11 | -$46.01M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | -$10.63M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$21.72M derived: sum of 2 quarters · filed 2016-02-11 | -$33.97M derived: sum of 3 quarters · filed 2016-02-11 | -$46.08M 10-K · filed 2016-02-11 | |||
| 2013-09-30 | -$11.10M 10-Q · filed 2014-11-04 | -$23.34M derived: sum of 2 quarters · filed 2014-11-04 | -$35.45M 10-Q · filed 2014-11-04 | -$25.99M derived: sum of 4 quarters · filed 2015-02-09 | |||
| 2013-06-30 | -$12.24M 10-Q · filed 2014-08-06 | -$24.36M 10-Q · filed 2014-08-06 | -$14.89M derived: sum of 3 quarters · filed 2015-02-09 | -$17.81M derived: sum of 4 quarters · filed 2015-02-09 | |||
| 2013-03-31 | -$12.12M 10-Q · filed 2014-05-01 | -$2.65M derived: sum of 2 quarters · filed 2015-02-09 | -$5.56M derived: sum of 3 quarters · filed 2015-02-09 | -$6.08M derived: sum of 4 quarters · filed 2015-02-09 | |||
| 2012-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $6.55M derived: sum of 2 quarters · filed 2015-02-09 | $6.04M derived: sum of 3 quarters · filed 2015-02-09 | $5.11M 10-K · filed 2015-02-09 | |||
| 2012-09-30 | -$2.92M 10-Q · filed 2013-10-29 | -$3.43M derived: sum of 2 quarters · filed 2013-10-29 | -$4.36M 10-Q · filed 2013-10-29 | -$2.96M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | -$517.00K 10-Q · filed 2013-07-26 | -$1.44M 10-Q · filed 2013-07-26 | -$40.00K derived: sum of 3 quarters · filed 2014-02-11 | $31.20M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | -$926.00K 10-Q · filed 2013-05-02 | $477.00K derived: sum of 2 quarters · filed 2014-02-11 | $31.72M derived: sum of 3 quarters · filed 2014-02-11 | $33.73M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2011-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $32.65M derived: sum of 2 quarters · filed 2014-02-11 | $34.65M derived: sum of 3 quarters · filed 2014-02-11 | $37.53M 10-K · filed 2014-02-11 | |||
| 2011-09-30 | $31.24M 10-Q · filed 2012-10-31 | $33.25M derived: sum of 2 quarters · filed 2012-10-31 | $36.13M 10-Q · filed 2012-10-31 | ||||
| 2011-06-30 | $2.01M 10-Q · filed 2012-07-31 | $4.89M 10-Q · filed 2012-07-31 | |||||
| 2011-03-31 | $2.88M 10-Q · filed 2012-05-02 | ||||||
| 2010-12-31 | -$9.22M 10-K · filed 2013-02-08 | ||||||
| 2009-12-31 | -$48.26M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |